Fundraising of €1.2M from Uni.Fund for EVO Human Performance
The latest addition to Uni.Fund’s portfolio is EVO HUMAN PERFORMANCE (https://evo4hp.com/), a start-up active in software development and digital health. EVO HUMAN PERFORMANCE will use the investment to expand its operations internationally and focus on further developing advanced tools for enhancing human performance.
EVO HUMAN PERFORMANCE is the first biomechanics company to study human structure through engineering, quantifying parameters related to athletic performance. Its flagship product, ARTEMYS, is an integrated system for monitoring performance, load management, musculoskeletal analysis, and creating a digital identity, initially for high-intensity professional athletes and eventually for anyone seeking to understand their optimal self. EVO HUMAN PERFORMANCE is entering the digital health space dynamically, creating a common language for everyone involved in professional sports based on the principles of a global system (System International) where all parties can speak and understand the same terms. For the first time, performance software is rooted in scientifically accepted measurable values, establishing strong foundations in Engineering and Mathematics (objects) ready for any use and user.
EVO HUMAN PERFORMANCE is redefining the field and invites you to step into the future today. You are one click away from your personalized model that combines a dynamic mathematical load/unload function with a digital twin of your musculoskeletal system.
EVO HUMAN PERFORMANCE already counts major European clubs among its clients and is poised to become the next golden standard. According to a recent sifted list of the fastest-growing startups in Southern Europe, EVO HP ranks 22nd and is committed to providing high-precision technological solutions in digital health on a global scale, starting from Greece.
With this €1.2M funding round, the company aims to accelerate commercial growth and develop dissemination tools, always considering that the company’s research and development department is an integral part of its identity and remains self-funded.
Regarding the partnership with Uni.Fund, Dr. Sophia Pomakidou, CEO of the company, stated: ‘We are grateful for the relationship we have developed with each member of Uni.Fund and all of them together. This sense of togetherness with a shared purpose is what we sought, to go as far as possible. I will refer to Aristotle, who reminds us that it is a mark of an educated mind to entertain a thought without always accepting it. In our case, we enjoy both evolution and mutual acceptance.’
On Uni.Fund’s side, Dora Trachana, Partner at Uni.Fund, commented: ‘With our investment in EVO HUMAN PERFORMANCE, we continue to believe in the commercial utilization of research outcomes while supporting the company’s dynamic commercial growth in Greece and abroad. The team, with very deep technological knowledge, can have a significant impact on transforming the field of professional sports and optimizing athletic performance through cutting-edge technologies and scientific methods.’
